×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BEAM – beam therapeutics inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BEAM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
02:42 pm
beam
Beam Therapeutics: Strong Buy On BEAM-101 Progress And In Vivo LNP Shots On Goal [Seeking Alpha]
Low
Report
Beam Therapeutics: Strong Buy On BEAM-101 Progress And In Vivo LNP Shots On Goal [Seeking Alpha]
11/27
07:07 pm
beam
Beam Therapeutics (BEAM) Earnings Transcript [Yahoo! Finance]
Low
Report
Beam Therapeutics (BEAM) Earnings Transcript [Yahoo! Finance]
11/26
06:43 am
beam
Beam Therapeutics (NASDAQ:BEAM) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Beam Therapeutics (NASDAQ:BEAM) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
11/24
09:07 am
beam
Beam Therapeutics (NASDAQ:BEAM) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
Medium
Report
Beam Therapeutics (NASDAQ:BEAM) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
11/18
08:09 am
beam
Gene Editing Pioneer David Liu: Fixing Baby's Rare Disease Heralds New Medical Era [Forbes]
Low
Report
Gene Editing Pioneer David Liu: Fixing Baby's Rare Disease Heralds New Medical Era [Forbes]
11/17
11:03 am
beam
Beam Therapeutics (NASDAQ:BEAM) had its "speculative buy" rating reaffirmed by analysts at Benchmark Co..
Low
Report
Beam Therapeutics (NASDAQ:BEAM) had its "speculative buy" rating reaffirmed by analysts at Benchmark Co..
11/12
07:00 am
beam
Beam Therapeutics to Participate in 2025 Jefferies London Healthcare Conference
Low
Report
Beam Therapeutics to Participate in 2025 Jefferies London Healthcare Conference
11/10
08:28 pm
beam
Clear Street Raises PT on Beam Therapeutics (BEAM) to $37 Following Q3 Results [Yahoo! Finance]
Medium
Report
Clear Street Raises PT on Beam Therapeutics (BEAM) to $37 Following Q3 Results [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/5
11:27 am
beam
Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: FMR LLC
11/4
07:12 am
beam
Form 10-Q Beam Therapeutics Inc. For: Sep 30
Low
Report
Form 10-Q Beam Therapeutics Inc. For: Sep 30
11/4
07:07 am
beam
Form 8-K Beam Therapeutics Inc. For: Nov 04
Medium
Report
Form 8-K Beam Therapeutics Inc. For: Nov 04
10/29
01:14 pm
beam
Form 4 Beam Therapeutics Inc. For: Oct 27 Filed by: FMR LLC
Medium
Report
Form 4 Beam Therapeutics Inc. For: Oct 27 Filed by: FMR LLC
10/8
03:38 pm
beam
Form 4 Beam Therapeutics Inc. For: Oct 06 Filed by: FMR LLC
Low
Report
Form 4 Beam Therapeutics Inc. For: Oct 06 Filed by: FMR LLC
10/3
04:15 pm
beam
Form 4 Beam Therapeutics Inc. For: Oct 01 Filed by: Cavanagh Bethany J
Low
Report
Form 4 Beam Therapeutics Inc. For: Oct 01 Filed by: Cavanagh Bethany J
10/3
04:10 pm
beam
Form 4 Beam Therapeutics Inc. For: Oct 01 Filed by: Bellon Christine
Low
Report
Form 4 Beam Therapeutics Inc. For: Oct 01 Filed by: Bellon Christine
10/3
04:05 pm
beam
Form 4 Beam Therapeutics Inc. For: Oct 01 Filed by: Evans John M.
Low
Report
Form 4 Beam Therapeutics Inc. For: Oct 01 Filed by: Evans John M.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/11
Form 8-K Beam Therapeutics Inc. For: Feb 10
14.5%
3/17 Keros Therapeutics on deck for IPO [Seeking Alpha] 12.8%
2/7 Form 424B4 Beam Therapeutics Inc. 9.7%
2/11 Beam Therapeutics Announces Pricing of Initial Public Offering 8.6%
4/28 Beam Therapeutics to Present First Data Highlighting Base Editing Program for Alpha-1 Antitrypsin Deficiency at 23rd ASGCT Annual Meeting 3.6%
3/4 Beam Therapeutics Inc (NASDAQ: BEAM) had its "outperform" rating re-affirmed by analysts at Wedbush. 3.6%
3/30 Form 10-K Beam Therapeutics Inc. For: Dec 31 2.9%
3/17 Keros Therapeutics on deck for IPO [Seeking Alpha] 12.8%
2/7 Form 424B4 Beam Therapeutics Inc. 9.7%
2/11 Beam Therapeutics Announces Pricing of Initial Public Offering 8.6%
4/28 Beam Therapeutics to Present First Data Highlighting Base Editing Program for Alpha-1 Antitrypsin Deficiency at 23rd ASGCT Annual Meeting 3.6%
3/4 Beam Therapeutics Inc (NASDAQ: BEAM) had its "outperform" rating re-affirmed by analysts at Wedbush. 3.6%
3/30 Form 10-K Beam Therapeutics Inc. For: Dec 31 2.9%
TOP News Decliners
3/16
Beam Therapeutics Announces Key R&D Appointments
-26.9%
2/5 Form 3 Beam Therapeutics Inc. For: Feb 05 Filed by: Burrell Terry-Ann -21.9%
2/24 Form S-8 Beam Therapeutics Inc. -6.6%
3/5 Form SEC STAFF LETTER Beam Therapeutics Inc. -2.4%
3/30 Beam Therapeutics Reports Business Updates and Full Year 2019 Financial Results -0.3%
2/5 Form 3 Beam Therapeutics Inc. For: Feb 05 Filed by: Burrell Terry-Ann -21.9%
2/24 Form S-8 Beam Therapeutics Inc. -6.6%
3/5 Form SEC STAFF LETTER Beam Therapeutics Inc. -2.4%
3/30 Beam Therapeutics Reports Business Updates and Full Year 2019 Financial Results -0.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: